Author： Rodon Jordi Iniesta Maria D Papadopoulos Kyriakos
Publisher： Informa Healthcare
ISSN： 1354-3784
Source： Expert Opinion on Investigational Drugs, Vol.18, Iss.1, 2009-01, pp. : 31-43
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Discussion of PARP inhibitors in cancer therapy
Pharmaceutical Patent Analyst, Vol. 2, Iss. 6, 2013-11 ,pp. :
Access to resources
Recommend
Parp Inhibitors for the Treatment of Ovarian Cancer
Current Cancer Drug Targets, Vol. 18, Iss. 9, 2018-11 ,pp. :
New inhibitors of poly(ADP-ribose) polymerase (PARP)
Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 11, 2004-11 ,pp. :